103 related articles for article (PubMed ID: 9004918)
1. Is TISCH a suitable tracer for in vivo study of modifications of the dopamine D-1 receptor?
Pellevoisin C; Chalon S; Kung HF; Besnard JC; Guilloteau D
Nucl Med Biol; 1996 Jan; 23(1):75-8. PubMed ID: 9004918
[TBL] [Abstract][Full Text] [Related]
2. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
Billings JJ; Kung MP; Chumpradit S; Mozley D; Alavi A; Kung HF
J Neurochem; 1992 Jan; 58(1):227-36. PubMed ID: 1530770
[TBL] [Abstract][Full Text] [Related]
3. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
[TBL] [Abstract][Full Text] [Related]
4. Autoradiographic study of striatal dopamine re-uptake sites and dopamine D1 and D2 receptors in a 6-hydroxydopamine and quinolinic acid double-lesion rat model of striatonigral degeneration (multiple system atrophy) and effects of embryonic ventral mesencephalic, striatal or co-grafts.
Puschban Z; Scherfler C; Granata R; Laboyrie P; Quinn NP; Jenner P; Poewe W; Wenning GK
Neuroscience; 2000; 95(2):377-88. PubMed ID: 10658617
[TBL] [Abstract][Full Text] [Related]
5. An autoradiographic study of the differential effects of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline (EEDQ) on striatal and extrastriatal D-1 and D-2 dopamine receptors in the rat.
Gnanalingham KK; Hunter AJ; Jenner P; Marsden CD
Neuropharmacology; 1994 May; 33(5):647-55. PubMed ID: 7936100
[TBL] [Abstract][Full Text] [Related]
6. Iodinated PK 11195 as an ex vivo marker of neuronal injury in the lesioned rat brain.
Chalon S; Pellevoisin C; Bodard S; Vilar MP; Besnard JC; Guilloteau D
Synapse; 1996 Dec; 24(4):334-9. PubMed ID: 10638824
[TBL] [Abstract][Full Text] [Related]
7. Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra.
Hemsley KM; Crocker AD
Neuropsychopharmacology; 2001 Oct; 25(4):514-26. PubMed ID: 11557165
[TBL] [Abstract][Full Text] [Related]
8. D-1 dopamine receptor changes after striatal quinolinic acid lesion.
Barone P; Tucci I; Parashos SA; Chase TN
Eur J Pharmacol; 1987 Jun; 138(1):141-5. PubMed ID: 2957219
[TBL] [Abstract][Full Text] [Related]
9. Differential modulation of dopamine D1-receptor binding and mRNA expression in the basal ganglia by the D1-receptor antagonist, SCH-23390.
Yu J; Coirini H; Källström L; Wiesel FA; Johnson AE
Synapse; 1998 Sep; 30(1):38-48. PubMed ID: 9704879
[TBL] [Abstract][Full Text] [Related]
10. Positron emission tomography and ex vivo and in vitro autoradiography studies on dopamine D2-like receptor degeneration in the quinolinic acid-lesioned rat striatum: comparison of [11C]raclopride, [11C]nemonapride and [11C]N-methylspiperone.
Ishiwata K; Ogi N; Hayakawa N; Umegaki H; Nagaoka T; Oda K; Toyama H; Endo K; Tanaka A; Senda M
Nucl Med Biol; 2002 Apr; 29(3):307-16. PubMed ID: 11929700
[TBL] [Abstract][Full Text] [Related]
11. Glial cell line-derived neurotrophic factor attenuates the excitotoxin-induced behavioral and neurochemical deficits in a rodent model of Huntington's disease.
Araujo DM; Hilt DC
Neuroscience; 1997 Dec; 81(4):1099-110. PubMed ID: 9330371
[TBL] [Abstract][Full Text] [Related]
12. Radioiodinated tracers for the evaluation of dopamine receptors in the neonatal rat brain after hypoxic-ischemic injury.
Zouakia A; Chalon S; Kung HF; Dognon AM; Saliba E; Besnard JC; Guilloteau D
Eur J Nucl Med; 1994 Jun; 21(6):488-92. PubMed ID: 8082661
[TBL] [Abstract][Full Text] [Related]
13. The effects of chronic continuous versus intermittent levodopa treatments on striatal and extrastriatal D1 and D2 dopamine receptors and dopamine uptake sites in the 6-hydroxydopamine lesioned rat--an autoradiographic study.
Gnanalingham KK; Robertson RG
Brain Res; 1994 Mar; 640(1-2):185-94. PubMed ID: 8004447
[TBL] [Abstract][Full Text] [Related]
14. Lithium suppresses excitotoxicity-induced striatal lesions in a rat model of Huntington's disease.
Wei H; Qin ZH; Senatorov VV; Wei W; Wang Y; Qian Y; Chuang DM
Neuroscience; 2001; 106(3):603-12. PubMed ID: 11591460
[TBL] [Abstract][Full Text] [Related]
15. Intrastriatal microinjection of sodium nitroprusside induces cell death and reduces binding of dopaminergic receptors.
Yanamoto K; Hosoi R; Uesaka Y; Abe K; Tsukada H; Inoue O
Synapse; 2003 Nov; 50(2):137-43. PubMed ID: 12923816
[TBL] [Abstract][Full Text] [Related]
16. Asymmetrical changes of dopamine receptors in the striatum after unilateral dopamine depletion.
Xu ZC; Ling G; Sahr RN; Neal-Beliveau BS
Brain Res; 2005 Mar; 1038(2):163-70. PubMed ID: 15757632
[TBL] [Abstract][Full Text] [Related]
17. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
Yokoyama C; Okamura H
J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
[TBL] [Abstract][Full Text] [Related]
18. Topography of substantia nigra innervation by D1 receptor-containing striatal neurons.
Altar CA; Hauser K
Brain Res; 1987 Apr; 410(1):1-11. PubMed ID: 2953407
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro binding of [
Zhang Y; Li G; Sun Y; Hong H; Li L; Luo Y; Wang R; Zhu L; Kung HF; Zhu J
J Labelled Comp Radiopharm; 2022 Dec; 65(14):354-360. PubMed ID: 36261868
[TBL] [Abstract][Full Text] [Related]
20. Localization of high affinity [3H]glibenclamide binding sites within the substantia nigra zona reticulata of the rat brain.
Hicks GA; Hudson AL; Henderson G
Neuroscience; 1994 Jul; 61(2):285-92. PubMed ID: 7969909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
